Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors

Krystyna Golembiowska, Thomas D. White, Jana Sawynok

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Abstract

Adenosine, a modulator of pain processing in the spinal cord, is metabolized by adenosine kinase and adenosine deaminase. In this study we determined which of these mechanisms is more important for the regulation of endogenous adenosine levels in the rat spinal cord. The effects of the adenosine kinase inhibitors, 5′-deoxyadenosine (NH2dAD) and iodotubercidin (IOT), and the adenosine deaminase inhibitor, 2′-deoxycoformycin (DCF), on adenosine release in a spinal cord superfusion model were studied. DCF markedly increased basal adenosine levels detected in perfusates and was more potent than NH2dAD and IOT in this regard. Coadministration of DCF with NH2dAD produced an enhanced effect compared to the inhibitors alone. NH2dAD, but not DCF, potentiated morphine-evoked adenosine release. These results suggest that adenosine deaminase may be the predominant pathway for adenosine metabolism in this experimental model.

Original languageEnglish
Pages (from-to)315-320
Number of pages6
JournalBrain Research
Volume699
Issue number2
DOIs
Publication statusPublished - Nov 20 1995

Bibliographical note

Funding Information:
This work was supported by the Medical Research Council of Canada. We thank Parke Davies Pharmaceuticals for the provision of 2'-deoxycoformycin.

ASJC Scopus Subject Areas

  • General Neuroscience
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

PubMed: MeSH publication types

  • Journal Article
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors'. Together they form a unique fingerprint.

Cite this